Epstein-Barr virus (EBV) infects epithelial cells and is associated with epithelial malignancies. Although EBV reactivation is induced by epithelial differentiation, the available methods for differentiation are not widely used.
KEYWORDS: ALI, EBV
ABSTRACT
Epstein-Barr virus (EBV) infects epithelial cells and is associated with epithelial malignancies. Although EBV reactivation is induced by epithelial differentiation, the available methods for differentiation are not widely used. In a recent study, Caves et al. (mSphere 3:e00152-18, 2018, https://doi.org/10.1128/mSphere.00152-18) explored the use of a new transwell-based air-liquid interface (ALI) system to differentiate EBV-infected nasopharyngeal carcinoma cells. They found that cells cultured in the ALI system expressed markers of differentiation and supported complete EBV reactivation. This system offers an easy method for differentiation that could be widely adopted. This system could be extended to other epithelial cell types.
COMMENTARY
Epstein-Barr virus (EBV) is a ubiquitous gammaherpesvirus that establishes lifelong infections and has latent and lytic stages of the viral life cycle (1). EBV infects B cells and epithelial cells and is associated with several lymphomas and epithelial malignancies, including gastric cancer and nasopharyngeal carcinoma (NPC) (1). While B cells maintain the latent reservoir of EBV, epithelial cells in the oral mucosa are likely a major compartment for viral replication, as EBV is transmitted through saliva (2–4). However, the study of EBV replication in epithelial cells has been hampered by the lack of robust in vitro model systems. NPC lines lose EBV genomes during cell line establishment (5, 6), and most epithelial cells are difficult to infect. Furthermore, in monolayers of some epithelial cell types, induction of the lytic cycle with histone deacetylase or protein kinase C inhibitors can be abortive (7) and may not reflect authentic reactivation pathways in vivo. Recent advances have been made in studying EBV infection of epithelial cells with the use of the three-dimensional organotypic raft culture system, which faithfully recapitulates epithelial differentiation. This system involves seeding cells on a feeder cell-containing collagen plug that is lifted to an air-liquid interface (ALI) to induce differentiation. Differentiated cells can be efficiently infected with EBV via the apical surface, and virus disseminates throughout the raft (8). Additionally, cells that have been latently infected with EBV can be differentiated, which induces viral reactivation (9). Thus, differentiation of epithelial cells is critical for the study of EBV in this cell type.
As the organotypic raft culture system is not widely used, Caves et al. explored the use of a transwell-based ALI culture system to probe EBV replication in differentiated epithelial cells (10). The ALI system is conventionally used to polarize primary airway epithelial cells. In this system, cells are seeded on permeable transwell membranes that are thinly coated with collagen and are exposed to air by the removal of media from the apical chamber. If effective, the ALI method could be easily adopted across the field. Caves et al. used ALI to culture HK1 cells, an NPC line in which EBV genomes could not be detected after cell line establishment but which was subsequently latently infected in vitro (11). They showed that ALI cultures of HK1 NPC cells express two markers of differentiation, keratin 10 and involucrin, and support complete reactivation of EBV as demonstrated by expression of all viral genes, genome replication, and assembly of virions. It is somewhat surprising that markers of differentiation were induced in these cultures as transformed cells generally lose the ability to differentiate. In fact, C666-1 cells, representing another NPC line that maintained latent EBV infection during cell line establishment, were not capable of forming an intact epithelium and could not be cultured in the ALI system. As NPC is classified into several subtypes based on differentiation (12), perhaps the success of HK1 versus other NPC lines depends on the NPC subtype from which the line was derived. Although EBV is mostly latent in NPC, reactivation of latent EBV is thought to contribute to the carcinogenesis of NPC (13). Thus, this method allows the study of EBV replication and pathogenesis in HK1 NPC cells.
The degree to which these ALI cultures recapitulate epithelial differentiation remains unclear. The use of histology and immunohistochemistry could reveal whether or not these cultures form a stratified epithelium with distinct layers. Furthermore, how closely the ALI system mimics the organotypic raft culture system could be assessed by examining whether ALI cultures are infectible with EBV through the apical surface. Ultimately, ALI cultures may serve as a reasonable complement to the organotypic raft culture system, which is considered the gold standard in epithelial differentiation models.
The views expressed in this Commentary do not necessarily reflect the views of this journal or of ASM.
Footnotes
For the article discussed, see https://doi.org/10.1128/mSphere.00152-18.
REFERENCES
- 1.Young LS, Yap LF, Murray PG. 2016. Epstein-Barr virus: more than 50 years old and still providing surprises. Nat Rev Cancer 16:789–802. doi: 10.1038/nrc.2016.92. [DOI] [PubMed] [Google Scholar]
- 2.Borza CM, Hutt-Fletcher LM. 2002. Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat Med 8:594–599. doi: 10.1038/nm0602-594. [DOI] [PubMed] [Google Scholar]
- 3.Jiang R, Scott RS, Hutt-Fletcher LM. 2006. Epstein-Barr virus shed in saliva is high in B-cell-tropic glycoprotein gp42. J Virol 80:7281–7283. doi: 10.1128/JVI.00497-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Hadinoto V, Shapiro M, Sun CC, Thorley-Lawson DA. 2009. The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output. PLoS Pathog 5:e1000496. doi: 10.1371/journal.ppat.1000496. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Lin CT, Wong CI, Chan WY, Tzung KW, Ho JK, Hsu MM, Chuang SM. 1990. Establishment and characterization of two nasopharyngeal carcinoma cell lines. Lab Invest 62:713–724. [PubMed] [Google Scholar]
- 6.Dittmer DP, Hilscher CJ, Gulley ML, Yang EV, Chen M, Glaser R. 2008. Multiple pathways for Epstein-Barr virus episome loss from nasopharyngeal carcinoma. Int J Cancer 123:2105–2112. doi: 10.1002/ijc.23685. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Hui KF, Ho DN, Tsang CM, Middeldorp JM, Tsao GS, Chiang AK. 2012. Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma. Int J Cancer 131:1930–1940. doi: 10.1002/ijc.27439. [DOI] [PubMed] [Google Scholar]
- 8.Temple RM, Zhu J, Budgeon L, Christensen ND, Meyers C, Sample CE. 2014. Efficient replication of Epstein-Barr virus in stratified epithelium in vitro. Proc Natl Acad Sci U S A 111:16544–16549. doi: 10.1073/pnas.1400818111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Nawandar DM, Wang A, Makielski K, Lee D, Ma S, Barlow E, Reusch J, Jiang R, Wille CK, Greenspan D, Greenspan JS, Mertz JE, Hutt-Fletcher L, Johannsen EC, Lambert PF, Kenney SC. 2015. Differentiation-dependent KLF4 expression promotes lytic Epstein-Barr virus infection in epithelial cells. PLoS Pathog 11:e1005195. doi: 10.1371/journal.ppat.1005195. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Caves EA, Cook SA, Lee N, Stoltz D, Watkins S, Shair KH. 2018. Air-liquid interface method to study Epstein-Barr virus pathogenesis in nasopharyngeal epithelial cells. mSphere 3:e00152-18. doi: 10.1128/mSphere.00152-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Lo AK, Lo KW, Tsao SW, Wong HL, Hui JW, To KF, Hayward DS, Chui YL, Lau YL, Takada K, Huang DP. 2006. Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells. Neoplasia 8:173–180. doi: 10.1593/neo.05625. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Raab-Traub N. 2015. Nasopharyngeal carcinoma: an evolving role for the Epstein-Barr virus. Curr Top Microbiol Immunol 390:339–363. doi: 10.1007/978-3-319-22822-8_14. [DOI] [PubMed] [Google Scholar]
- 13.Cao Y. 2017. EBV based cancer prevention and therapy in nasopharyngeal carcinoma. NPJ Precis Oncol 1:10. doi: 10.1038/s41698-017-0018-x. [DOI] [PMC free article] [PubMed] [Google Scholar]